Revision history of "Targeted therapies: Tyrosine-kinase inhibitors--new standard for NSCLC therapy" (Q42845478)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 August 2024

  • curprev 08:1008:10, 11 August 2024 Cewbot talk contribs 38,496 bytes +1,047 Changed label, description and/or aliases in en, fr, it, es, pt, sq, pl, cs, sk, sv, da, nl, lt, sl, sr, bg, ru, vi, tr, de, zh-hant, zh-hans, nan, ja, tg-latn, en-gb, pt-br, sr-ec, zh, zh-tw, zh-hk, zh-mo, yue, zh-cn, zh-sg, zh-my, wuu: Modify PubMed ID: 20981125 citation data from NCBI, Europe PMC and CrossRef undo

16 July 2024

11 September 2023

2 March 2022

22 October 2021

16 September 2021

21 February 2021

30 August 2019

26 July 2019

24 January 2019

5 January 2019

8 November 2017